|

BI 765049 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 1: 2

Top Sponsors

  • Boehringer Ingelheim2

Indications

  • Cancer2
  • Liver Disease1
  • Gastrointestinal Cancer1
  • Pancreatic Ductal Adenocarcinoma1
  • Colorectal Carcinoma1

Other1 trial

A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Phase 1

Los Angeles, California1 trial

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

Valkyrie Clinical Trials

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.